Connect with us

Technology

Generative AI Instantly Elevates the Aptitude of Knowledge Workers: Consultants Achieve up to 49 Percentage Point Improvement on Complex Tasks Outside Their Skillset

Published

on

New Research by the BCG Henderson Institute Examines Impact of GenAI on Consultants’ Performance of Data Science Tasks Beyond Their Existing Capabilities

BOSTON, Sept. 5, 2024 /PRNewswire/ — Generative AI (GenAI) is creating a new type of knowledge worker who can code faster and summarize documents instantly. But can the tool also enable people to meet the shifting demands of their roles? A new scientific experiment conducted by the BCG Henderson Institute in collaboration with BCG X and Emma Wiles from Boston University, as described in GenAI Doesn’t Just Increase Productivity. It Expands Capabilities, examines what happens when, instead of using GenAI to improve performance within their current skillset, people use the technology to complete tasks beyond their existing capabilities.

In the experiment, 480 BCG consultants completed two of three short tasks that mimic the daily activities of a data scientist: writing Python code to merge and clean datasets, building a predictive model, and validating ChatGPT-generated statistical analyses. These tasks were designed to present a significant challenge for any consultant and could not be fully automated by the GenAI tool (Enterprise ChatGPT with GPT-4 and its Advanced Data Analysis Feature). To help evaluate participants’ performance, their results were compared with those of 44 BCG data scientists who worked without the assistance of GenAI.

“Our findings suggest that GenAI-augmented workers can adeptly handle new tasks beyond their existing skills in fields that are in the tool’s capabilities,” said Dan Sack, a BCG managing director and partner, and coauthor of the study. “Executives need to be ready for this future, redefining expertise and identifying the skills to grow and retain their talent for the long term.”

Instant Aptitude Expansion for New Tasks 

When using GenAI, the consultants in the study were able to instantly expand their aptitude for new tasks. Even when they had no experience in coding or statistics, consultants with access to GenAI were able to write code, appropriately apply machine learning models, and correct erroneous statistical processes. The biggest skill expansion was observed in coding, where participants were tested on their ability to write code in Python, a common programming language by data scientists. Participants who used GenAI achieved an average score equivalent to 86% of the benchmark set by data scientists, a 49 percentage point improvement over participants not using GenAI. The GenAI-augmented group also finished the task roughly 10% faster than the data scientists.

GenAI as a Powerful Brainstorming Partner

For the predictive analytics task, the experiment participants encountered a significant challenge: neither they nor the GenAI tool had a high level of proficiency in this area. Predictive analytics was the task which the GenAI-augmented consultant was least likely to perform on par with a data scientist, regardless of previous experience in coding or statistics, as the GenAI tool is likely to misunderstand the reliability prompt without trial and error or rephrasing of the question. As a result, participants with access to GenAI were more likely to be led astray than their nonaugmented counterparts.

With the support of GenAI, participants were able to brainstorm with the tool, combining their knowledge with GenAI’s knowledge to discover new modelling techniques and identify the correct steps to solve the problem successfully. The GenAI-augmented participants were 15 percentage points more likely to select and appropriately apply machine-learning methods than their counterparts who did not have access to GenAI.

“Doing GenAI” Doesn’t Mean Learning to Do 

Reskilling is defined as individuals gaining new capabilities or knowledge that enables them to move into a new job or industry. The study revealed that GenAI-augmented workers were in a sense “reskilled” in that they gained new capabilities that were beyond what either the human or GenAI could do on their own. But GenAI was only an exoskeleton; the humans alone were not intrinsically reskilled, because “doing” with GenAI does not immediately nor inherently mean “learning to do.”

While each participant was assigned just two of the three tasks in the experiment, everyone was given a final assessment with questions related to all three tasks to test how much they learned. Everyone was asked a coding syntax question, even though not all participants had done a coding task. Surprisingly, those who did this task scored the same as those who didn’t, indicating that performing the data science tasks did not increase their knowledge. It should be noted that the participants were not informed that they would be tested, and it is likely that with repetition and intention, learning would happen.

In addition, GenAI-augmented participants with moderate coding experience performed 10 to 20 percentage points better on all three tasks than their peers who self-identified as novices, even when coding was not involved. In fact, those with moderate coding experience were fully on par with data scientists for two of the three tasks—one of which had zero coding involved.

“As a parent, I often get asked what kids should study, and it’s something I think about when it comes to my own children,” said Sack. “This research has reinforced my belief that learning to code holds significant value, even if the prevailing opinion suggests that coding might be a thing of the past. It’s the engineering mindset that coding helps develop—like the ability to break down complex problems into manageable parts that can be efficiently tested and refined—that truly matters.”

Download the publication here:
https://www.bcg.com/publications/2024/gen-ai-increases-productivity-and-expands-capabilities

Media Contact:
Eric Gregoire:
+1 617 850 3783
gregoire.eric@bcg.com 

About the BCG Henderson Institute
The BCG Henderson Institute is the Boston Consulting Group’s think tank, dedicated to exploring and developing valuable new insights from business, technology, economics, and science.

The Institute engages leaders in provocative discussion and experimentation to expand the boundaries of business theory and practice and to translate innovative ideas from within and beyond business. For more ideas and inspiration from the Institute, please visit bcghendersoninstitute.com. To receive BHI’s latest research publications, please sign up here.

About Boston Consulting Group
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.

Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.

View original content to download multimedia:https://www.prnewswire.com/news-releases/generative-ai-instantly-elevates-the-aptitude-of-knowledge-workers-consultants-achieve-up-to-49-percentage-point-improvement-on-complex-tasks-outside-their-skillset-302238695.html

SOURCE Boston Consulting Group (BCG)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple

Published

on

By

The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.

AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.

The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.

The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.

The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.

According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.

The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.

Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.

The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.

The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.

What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html

SOURCE HelloNation

Continue Reading

Technology

CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group

Published

on

By

Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.

ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.

Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.

“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”

Key Challenges IT Leaders Face in Regulatory Response

Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:

Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.

Info-Tech’s Framework for Building a Regulatory IT Response Engine

To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:

Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.

Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.

The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.

For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026

Published

on

By

LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.

The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.

https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw

About Atomera

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html

SOURCE Atomera Incorporated

Continue Reading

Trending